Company overview
Basic information
Company name
Inerma, UAB
Company code
303340790
VAT code
LT100008689410
Registered address
Vilnius, Čiobiškio g. 6-69, LT-07181
Registration date
2014-07-01
Company age: 12 y. 2 mo.
Contact information
Edit data
Phone
Email
Not disclosed
(personal)
Website
https://www.winmau.lt
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
UAB "Inerma"
Company code: 303340790
Address: Vilnius, Čiobiškio g. 6-69, LT-07181
VAT code: LT100008689410
Download a detailed company report
Make confident decisions with all the information about Inerma, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Inerma, UAB (company code 303340790) is an operational private limited liability company registered in 2014. It is a privately owned Lithuanian company with a CEO-only governance structure and is classified as a micro business in the sector of national private non-financial companies. The company operates in retail sale of pharmaceutical products (EVRK G.47.73.00). Its registered address is in Vilnius, Ciobiškio g. 6-69, Vilniaus m. sav., Vilniaus apskr.
The company reported revenue of EUR 41.0K in 2025, slightly below the previous year, while still above the 2023 level. It remained loss-making, with net loss of EUR 13.9K in 2025, an improvement from EUR 16.3K in 2024 and EUR 23.8K in 2023. At the end of 2025, equity was negative at EUR 88.1K, liabilities stood at EUR 172.5K, and total assets were EUR 84.4K. The company had 3 average employees in 2023, 2024 and 2025, and 2 average employees so far in 2026, indicating a decline in staffing.
The company reported revenue of EUR 41.0K in 2025, slightly below the previous year, while still above the 2023 level. It remained loss-making, with net loss of EUR 13.9K in 2025, an improvement from EUR 16.3K in 2024 and EUR 23.8K in 2023. At the end of 2025, equity was negative at EUR 88.1K, liabilities stood at EUR 172.5K, and total assets were EUR 84.4K. The company had 3 average employees in 2023, 2024 and 2025, and 2 average employees so far in 2026, indicating a decline in staffing.